Citations (73)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Khalil Rafiqi, Camilla Bang Hoeks, Bo Løfgren, Martin Bødtker Mortensen & Jens M Bruun. (2023) Diagnostic Impact of Hs-CRP and IL-6 for Acute Coronary Syndrome in Patients Admitted to the ED with Chest Pain: Added Value to the HEART Score?. Open Access Emergency Medicine 15, pages 333-342.
Read now
Read now
Ahmed Salman, Mohamed Salman, Mohamed D Sarhan, Karim Maurice, Mohamed Tag El-Din, Ahmed Youssef, Reham Ahmed, Tarek Abouelregal, Hossam El-Din Shaaban, Ghada M K GabAllah & Mahmoud Gouda Omar. (2021) Changes of Urinary Cytokines in Non-Diabetic Obese Patients After Laparoscopic Sleeve Gastrectomy. International Journal of General Medicine 14, pages 825-831.
Read now
Read now
Richard Kones & Umme Rumana. (2017) Cardiometabolic diseases of civilization: history and maturation of an evolving global threat. An update and call to action. Annals of Medicine 49:3, pages 260-274.
Read now
Read now
Anna Rosiek & Krzysztof Leksowski. (2016) The risk factors and prevention of cardiovascular disease: the importance of electrocardiogram in the diagnosis and treatment of acute coronary syndrome. Therapeutics and Clinical Risk Management 12, pages 1223-1229.
Read now
Read now
Eva Skaleric, Milan Petelin, Boris Gaspirc & Uros Skaleric. (2012) Periodontal inflammatory burden correlates with C-reactive protein serum level. Acta Odontologica Scandinavica 70:6, pages 520-528.
Read now
Read now
Jingyi Lu, Ming Li, Rong Zhang, Cheng Hu, Congrong Wang, Feng Jiang, Weihui Yu, Wen Qin, Shanshan Tang & Weiping Jia. (2012) A Common Genetic Variant of FCN3/CD164L2 Is Associated With Essential Hypertension in a Chinese Population. Clinical and Experimental Hypertension 34:5, pages 377-382.
Read now
Read now
Richard Kones. (2011) Inflammation, C-reactive protein and cardiometabolic risk: how compelling is the potential therapeutic role of n.3 PUFAs in cardiovascular disease?. Clinical Lipidology 6:6, pages 627-630.
Read now
Read now
Richard Kones. (2011) Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Design, Development and Therapy 5, pages 325-380.
Read now
Read now
Articles from other publishers (65)
Ralf Martz Sulague, Nina Nicole M. Suan, Michael F. Mendoza & Carl J. Lavie. (2022) The associations between exercise and lipid biomarkers. Progress in Cardiovascular Diseases 75, pages 59-68.
Crossref
Crossref
Violeta J Rodriguez, John M Abbamonte, Manasi S Parrish, Deborah L Jones, Stephen Weiss, Suresh Pallikkuth, Michal Toborek, Maria L Alcaide, Dushyantha Jayaweera, Savita Pahwa, Tatjana Rundek, Barry E Hurwitz & Mahendra Kumar. (2021) Predicting cardiovascular risk using a novel risk score in young and middle-age adults with HIV: associations with biomarkers and carotid atherosclerotic plaque. International Journal of STD & AIDS 33:2, pages 144-155.
Crossref
Crossref
Kompal Gautam, Anjali Kapoor, Setu Mathur, ARizwan Ali, Aparna Choudhary & Arpana Shekhawat. (2022) Comparative evaluation of autogenous bone graft and autologous platelet-rich fibrin with and without 1.2 mg in situ rosuvastatin gel in the surgical treatment of intrabony defect in chronic periodontitis patients. Contemporary Clinical Dentistry 13:1, pages 69.
Crossref
Crossref
Michael Vaughn F. Mendoza, Sergey M. Kachur & Carl J. Lavie. 2022. Physical Exercise and Natural and Synthetic Products in Health and Disease. Physical Exercise and Natural and Synthetic Products in Health and Disease
93
117
.
Si-Min Yao, Pei-Pei Zheng, Yu-Hao Wan, Wei Dong, Guo-Bin Miao, Hua Wang & Jie-Fu Yang. (2021) Adding high-sensitivity C-reactive protein to frailty assessment to predict mortality and cardiovascular events in elderly inpatients with cardiovascular disease. Experimental Gerontology 146, pages 111235.
Crossref
Crossref
O. A. Mirolyubova, A. V. Kudryavtsev, E. O. Semchyugova, S. K. Malyutina & A. N. Ryabikov. (2020) C-reactive protein and its associations with сardiometabolic risk factors and echocardiographic indicators of heart failure: results of “Know your heart” study in Arkhangelsk. Kardiologiia 60:9, pages 68-75.
Crossref
Crossref
Olena lakunchykova, Maria Averina, Tom Wilsgaard, Hugh Watkins, Sofia Malyutina, Yulia Ragino, Ruth H Keogh, Alexander V Kudryavtsev, Vadim Govorun, Sarah Cook, Henrik Schirmer, Anne Elise Eggen, Laila Arnesdatter Hopstock & David A Leon. (2020) Why does Russia have such high cardiovascular mortality rates? Comparisons of blood-based biomarkers with Norway implicate non-ischaemic cardiac damage. Journal of Epidemiology and Community Health, pages jech-2020-213885.
Crossref
Crossref
Olena Iakunchykova, Maria Averina, Alexander V. Kudryavtsev, Tom Wilsgaard, Andrey Soloviev, Henrik Schirmer, Sarah Cook & David A. Leon. (2020) Evidence for a Direct Harmful Effect of Alcohol on Myocardial Health: A Large Cross‐Sectional Study of Consumption Patterns and Cardiovascular Disease Risk Biomarkers From Northwest Russia, 2015 to 2017. Journal of the American Heart Association 9:1.
Crossref
Crossref
Soon Jun Hong, Han Saem Jeong, Jin-Man Cho, Kiyuk Chang, Wook Bum Pyun, Youngkeun Ahn, Min Su Hyon, Woong Chol Kang, Jae-Hwan Lee & Hyo-Soo Kim. (2019) Efficacy and Safety of Triple Therapy With Telmisartan, Amlodipine, and Rosuvastatin in Patients With Dyslipidemia and Hypertension: The Jeil Telmisartan, Amlodipine, and Rosuvastatin Randomized Clinical Trial. Clinical Therapeutics 41:2, pages 233-248.e9.
Crossref
Crossref
M. I. Yalovenko. (2019) THE BLOOD PLASMA LEVEL OF HIGH SENSITIVITY C-REACTIVE PROTEIN AND MARKERS OF CHRONIC INFLAMMATION IN PATIENTS WITH ATRIAL FIBRILLATION, ARTERIAL HYPERTENSION, CORONARY ARTERY DISEASE AND HEART FAILURE. Bulletin of Problems Biology and Medicine 1:1, pages 203.
Crossref
Crossref
Rai Ajit K. Srivastava, Joseph A. Cornicelli, Bruce Markham & Charles L. Bisgaier. (2018) Gemcabene, a first-in-class lipid-lowering agent in late-stage development, down-regulates acute-phase C-reactive protein via C/EBP-δ-mediated transcriptional mechanism. Molecular and Cellular Biochemistry 449:1-2, pages 167-183.
Crossref
Crossref
Irene Ju, Emily Banks, Bianca Calabria, Angela Ju, Jason Agostino, Rosemary J Korda, Tim Usherwood, Karine Manera, Camilla S Hanson, Jonathan C Craig & Allison Tong. (2018) General practitioners’ perspectives on the prevention of cardiovascular disease: systematic review and thematic synthesis of qualitative studies. BMJ Open 8:11, pages e021137.
Crossref
Crossref
Dileep Pankaj, Ipshita Sahu, Ida Grace Kurian & A. R. Pradeep. (2018) Comparative evaluation of subgingivally delivered 1.2% rosuvastatin and 1% metformin gel in treatment of intrabony defects in chronic periodontitis: A randomized controlled clinical trial. Journal of Periodontology 89:11, pages 1318-1325.
Crossref
Crossref
John Munkhaugen, Jan Erik Otterstad, Toril Dammen, Erik Gjertsen, Torbjørn Moum, Einar Husebye & Lars Gullestad. (2018) The prevalence and predictors of elevated C-reactive protein after a coronary heart disease event. European Journal of Preventive Cardiology 25:9, pages 923-931.
Crossref
Crossref
J.A. Morantes Acevedo, J.C. Álvarez Vega & J. Sánchez Vergara. (2017) Effect of a single dose of pre-operative pravastatin on C-reactive protein levels and neutrophil/lymphocyte ratio in patients undergoing mastectomy for breast cancer. Revista Médica del Hospital General de México 80:4, pages 223-227.
Crossref
Crossref
C.P. Twine. (2017) The Relationship Between CRP and MACE: Controversial and Confounded. European Journal of Vascular and Endovascular Surgery 54:2, pages 234.
Crossref
Crossref
Shruti GargA.R. Pradeep. (2017) 1.2% Rosuvastatin and 1.2% Atorvastatin Gel Local Drug Delivery and Redelivery in the Treatment of Class II Furcation Defects: A Randomized Controlled Clinical Trial. Journal of Periodontology 88:3, pages 259-265.
Crossref
Crossref
Ju-Gyeong YoonSuJin SongJin Ah Cho. (2017) Association between nutrient intake and serum high sensitivity C-reactive protein level in Korean adults: Using the data from 2015 Korea National Health and Nutrition Examination Survey. Journal of Nutrition and Health 50:6, pages 565.
Crossref
Crossref
Qiling Li, Wei Xu, Xue Xue, Qi Wang, Lu Han, Wenzhi Li, Shulan Lv, Dong Liu, Jendai Richards, Zhujun Shen, Li Ma & Qing Song. (2016) Presence of multimeric isoforms of human C-reactive protein in tissues and blood. Molecular Medicine Reports 14:6, pages 5461-5466.
Crossref
Crossref
Arthur Fernandes Cortez, Elizabeth Silaid Muxfeldt, Claudia Regina Lopes Cardoso & Gil Fernando Salles. (2016) Prognostic Value of C-Reactive Protein in Resistant Hypertension. American Journal of Hypertension 29:8, pages 992-1000.
Crossref
Crossref
Laura V. Minard, Amber Corkum, Ingrid Sketris, Judith Fisher, Ying Zhang & Ahmed Saleh. (2016) Trends in Statin Use in Seniors 1999 to 2013: Time Series Analysis. PLOS ONE 11:7, pages e0158608.
Crossref
Crossref
Qian Ma, Yujie Zhou, Guangyao Zhai, Fei Gao, Linlin Zhang, Jianlong Wang, Qing Yang & Wanjun Cheng. (2015) Meta-Analysis Comparing Rosuvastatin and Atorvastatin in Reducing Concentration of C-Reactive Protein in Patients With Hyperlipidemia. Angiology 67:6, pages 526-535.
Crossref
Crossref
Mariola Herbet, Magdalena Izdebska, Iwona Piątkowska-Chmiel, Ewa Poleszak & Ewa Jagiełło-Wójtowicz. (2016) Estimation of oxidative stress parameters in rats after simultaneous administration of rosuvastatin with antidepressants. Pharmacological Reports 68:1, pages 172-176.
Crossref
Crossref
A.R. Pradeep, Shruti Karvekar, Kanika Nagpal, Kaushik Patnaik, Arjun Raju & Priyanka Singh. (2016) Rosuvastatin 1.2 mg In Situ Gel Combined With 1:1 Mixture of Autologous Platelet-Rich Fibrin and Porous Hydroxyapatite Bone Graft in Surgical Treatment of Mandibular Class II Furcation Defects: A Randomized Clinical Control Trial. Journal of Periodontology 87:1, pages 5-13.
Crossref
Crossref
Leonardo De Luca & Fabrizio Tomai. 2016. Biomarkers in Cardiovascular Disease. Biomarkers in Cardiovascular Disease
897
913
.
PI Altieri. (2015) The Metabolic Syndrome in Hispanics – The Role of Inflammation. Global Journal of Obesity, Diabetes and Metabolic Syndrome, pages 012-017.
Crossref
Crossref
Richard Kones & Umme Rumana. (2015) Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs. Drugs 75:11, pages 1201-1228.
Crossref
Crossref
A.R. Pradeep, Shruti Karvekar, Kanika Nagpal, Kaushik Patnaik, C.N. Guruprasad & K.M. Kumaraswamy. (2015) Efficacy of Locally Delivered 1.2% Rosuvastatin Gel To Non-Surgical Treatment of Patients With Chronic Periodontitis: A Randomized, Placebo-Controlled Clinical Trial. Journal of Periodontology 86:6, pages 738-745.
Crossref
Crossref
AYSE ERTURK, MEDINE CUMHUR CURE, ERKAN CURE, AYSEL KURT, AYSEGUL COPUR CICEK & SULEYMAN YUCE. (2015) Clinical potential of resistin as a novel prognostic biomarker for cellulitis. Experimental and Therapeutic Medicine 9:5, pages 1875-1880.
Crossref
Crossref
Thilanga Ruwanpathirana, Alice Owen & Christopher M. Reid. (2015) Review on Cardiovascular Risk Prediction. Cardiovascular Therapeutics 33:2, pages 62-70.
Crossref
Crossref
Satoshi Matsuo, Yuriko Saiki, Osamu Adachi, Shunsuke Kawamoto, Shinichi Fukushige, Akira Horii & Yoshikatsu Saiki. (2015) Single-dose rosuvastatin ameliorates lung ischemia–reperfusion injury via upregulation of endothelial nitric oxide synthase and inhibition of macrophage infiltration in rats with pulmonary hypertension. The Journal of Thoracic and Cardiovascular Surgery 149:3, pages 902-909.
Crossref
Crossref
Yongle Li, Yinyin Shu, Qing Ji, Jian Liu, Xiaoyun He & Weiyan Li. (2014) Attenuation of Morphine Analgesic Tolerance by Rosuvastatin in Naïve and Morphine Tolerance Rats. Inflammation 38:1, pages 134-141.
Crossref
Crossref
Tetiana V. Talaieva & Victor V. Bratus. (2015) Proteolytic Enzyme Combination Reduces Inflammation and Oxidative Stress and Improves Insulin Sensitivity in a Model of Metabolic Syndrome. Advances in Enzyme Research 03:01, pages 1-8.
Crossref
Crossref
Weiyan Li, Yongle Li, Sihai Zhu, Qin Ji, Yinyin Shu, Lidong Zhang & Jian Liu. (2015) Rosuvastatin attenuated the existing morphine tolerance in rats with L5 spinal nerve transection through inhibiting activation of astrocytes and phosphorylation of ERK42/44. Neuroscience Letters 584, pages 314-319.
Crossref
Crossref
Leonardo De Luca & Fabrizio Tomai. 2015. Biomarkers in Cardiovascular Disease. Biomarkers in Cardiovascular Disease
1
17
.
Juan Salazar, María Sofía Martínez, Mervin Chávez-Castillo, Victoria Núñez, Roberto Añez, Yaquelin Torres, Alexandra Toledo, Maricarmen Chacín, Carlos Silva, Enrique Pacheco, Joselyn Rojas & Valmore Bermúdez. (2014) C-Reactive Protein: An In-Depth Look into Structure, Function, and Regulation. International Scholarly Research Notices 2014, pages 1-11.
Crossref
Crossref
DILIDAER XILIFU, ABULIZI ABUDULA, NIJIATI REHEMU, LONG ZHAO, XINRONG ZHOU & XIANGYANG ZHANG. (2014) Effect of rosuvastatin on hyperuricemic rats and the protective effect on endothelial dysfunction. Experimental and Therapeutic Medicine 8:6, pages 1683-1688.
Crossref
Crossref
Yacov Shacham. (2014) Author's reply. Journal of Cardiology 64:4, pages 328-329.
Crossref
Crossref
Yavuzer Koza. (2014) The association between C-reactive protein level and left ventricular diastolic functions in patients with first ST-segment elevation myocardial infarction treated by primary coronary intervention. Journal of Cardiology 64:4, pages 328.
Crossref
Crossref
Viktor Čulić. (2014) Inflammation, coagulation, weather and arrhythmogenesis: Is there a linkage?. International Journal of Cardiology 176:1, pages 289-293.
Crossref
Crossref
T. Du & Z. Tan. (2014) Relationship between deep venous thrombosis and inflammatory cytokines in postoperative patients with malignant abdominal tumors. Brazilian Journal of Medical and Biological Research 47:11, pages 1003-1007.
Crossref
Crossref
QING KONG, XIAOMO LI, WEIFENG WU, FAN YANG, YANLI LIU, WENYIN LAI XIAOFEN PAN, MENGSHA GAO & YIMIN XUE. (2014) Increased circulating T-helper 22 cells in patients with dilated cardiomyopathy. Molecular Medicine Reports 10:1, pages 359-364.
Crossref
Crossref
G. T. Russo, A. Giandalia, E. L. Romeo, M. Marotta, A. Alibrandi, C. De Francesco, K. V. Horvath, B. Asztalos & D. Cucinotta. (2014) Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease. Journal of Endocrinological Investigation 37:3, pages 261-268.
Crossref
Crossref
Viviana Noriega, Fernando Sierralta, Juan Carlos Prieto, Pilar Zanetta & Hugo F. Miranda. (2014) Nitridergic Modulation of the Antinociceptive Activity of Rosuvastatin in Mice. Pharmacology & Pharmacy 05:01, pages 61-68.
Crossref
Crossref
Byung-Hee Oh, Rinambaan W.M. Kaligis, Yongjun Wang, Felix Eduardo R. Punzalan, Nijasri C. Suwanwela, Viet Lan Nguyen, Tsong-Hai Lee, Kui-Hian Sim, Yohji Itoh, Namrata Bahadur & Joy Leong. (2013) Survey of atherosclerotic disease in Asian subjects with cardiovascular disease risk factors who were not receiving lipid-lowering agents. International Journal of Cardiology 168:3, pages 2761-2766.
Crossref
Crossref
David J Pinato, Jasmeen Bains, Sashidhar Irkulla, Josh Pomroy, Bedri Ujam, David Gaze & Michael A Mendall. (2013) Advanced age influences the dynamic changes in circulating C-reactive protein following injury. Journal of Clinical Pathology 66:8, pages 695-699.
Crossref
Crossref
Nihal Ozturk, Nazmi Yaras, Asli Ozmen & Semir Ozdemir. (2013) Long-term administration of rosuvastatin prevents contractile and electrical remodelling of diabetic rat heart. Journal of Bioenergetics and Biomembranes 45:4, pages 343-352.
Crossref
Crossref
Omair Yousuf, Bibhu D. Mohanty, Seth S. Martin, Parag H. Joshi, Michael J. Blaha, Khurram Nasir, Roger S. Blumenthal & Matthew J. Budoff. (2013) High-Sensitivity C-Reactive Protein and Cardiovascular Disease. Journal of the American College of Cardiology 62:5, pages 397-408.
Crossref
Crossref
Qiling Li, Ting Kang, Xiaohua Tian, Yamin Ma, Min Li, Jendai Richards, Tameka Bythwood, Yueling Wang, Xu Li, Dong Liu, Li Ma & Qing Song. (2013) Multimeric Stability of Human C-reactive Protein in Archived Specimens. PLoS ONE 8:3, pages e58094.
Crossref
Crossref
Ban Liu, Wenliang Che, Hongwei Yan, Weidong Zhu & Hongbao Wang. (2013) Effects of Rosuvastatin vs. Simvastatin/ezetimibe on Arterial Wall Stiffness in Patients with Coronary Artery Disease. Internal Medicine 52:24, pages 2715-2719.
Crossref
Crossref
Gianni Belcaro, Andrea Ledda, Shu Hu, Maria Rosa Cesarone, Beatrice Feragalli & Mark Dugall. (2013) Grape Seed Procyanidins in Pre- and Mild Hypertension: A Registry Study. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-5.
Crossref
Crossref
John Frank & Ruth Jepson. 2013. Global Handbook on Noncommunicable Diseases and Health Promotion. Global Handbook on Noncommunicable Diseases and Health Promotion
3
19
.
Riccioni Graziano & Sblendorio Valeriana. (2012) Atherosclerosis: from biology to pharmacological treatment. Journal of Geriatric Cardiology 9:3, pages 305-317.
Crossref
Crossref
Claudia P Cabrera, Pau Navarro, Jennifer E Huffman, Alan F Wright, Caroline Hayward, Harry Campbell, James F Wilson, Igor Rudan, Nicholas D Hastie, Veronique Vitart & Chris S Haley. (2012) Uncovering Networks from Genome-Wide Association Studies via Circular Genomic Permutation. G3 Genes|Genomes|Genetics 2:9, pages 1067-1075.
Crossref
Crossref
Svitlana Demyanets, Kurt Huber & Johann Wojta. (2012) Vascular effects of glycoprotein130 ligands — Part II: Biomarkers and therapeutic targets. Vascular Pharmacology 57:1, pages 29-40.
Crossref
Crossref
Nabil G. Seidah, Steve Poirier, Maxime Denis, Rex Parker, Bowman Miao, Claudio Mapelli, Annik Prat, Hanny Wassef, Jean Davignon, Katherine A. Hajjar & Gaétan Mayer. (2012) Annexin A2 Is a Natural Extrahepatic Inhibitor of the PCSK9-Induced LDL Receptor Degradation. PLoS ONE 7:7, pages e41865.
Crossref
Crossref
Xianli Wu & Alexander G. Schauss. (2012) Mitigation of Inflammation with Foods. Journal of Agricultural and Food Chemistry 60:27, pages 6703-6717.
Crossref
Crossref
Oksana Mikhailovna Drapkina & Marina Viktorovna Kostyukevich. (2012) Statin use and risk of diabetes mellitus. Diabetes mellitus 15:2, pages 77-82.
Crossref
Crossref
Graziano Riccioni, Lorenza Speranza, Mirko Pesce, Salvatore Cusenza, Nicolantonio D’Orazio & Michael J. Glade. (2012) Novel phytonutrient contributors to antioxidant protection against cardiovascular disease. Nutrition 28:6, pages 605-610.
Crossref
Crossref
Claudio NapoliValeria CrudeleAndrea SoricelliMohammed Al-OmranNicoletta VitaleTeresa InfanteFrancesco P. Mancini. (2012) Primary Prevention of Atherosclerosis. Circulation 125:19, pages 2363-2373.
Crossref
Crossref
Jiatao Ye, James N Kiage, Donna K Arnett, Alfred A Bartolucci & Edmond K Kabagambe. (2011) Short-term effect of fenofibrate on C-reactive protein: A meta-analysis of randomized controlled trials. Diabetology & Metabolic Syndrome 3:1.
Crossref
Crossref
Flor de la C. Heres-Álvarez & Amalia Peix-González. (2011) La proteína C reactiva como blanco terapéutico en la prevención cardiovascular: ¿ficción o realidad?. Revista Española de Cardiología Suplementos 11, pages 30-35.
Crossref
Crossref
Russell H. Samson & Deepak G. Nair. (2011) Influence and Critique of the JUPITER Trial (Statins v No Statins for Primary Prevention of Cardiovascular Events in Patients with Normal Lipids and Elevated C-Reactive Protein). Seminars in Vascular Surgery 24:3, pages 172-179.
Crossref
Crossref
Andreas Pfützner, Markolf Hanefeld, Lida A. Dekordi, Jürgen Müller, Iris Kleine, Winfried Fuchs & Thomas Forst. (2011) Effect of Pioglitazone and Ramipril on Biomarkers of Low-Grade Inflammation and Vascular Function in Nondiabetic Patients with Increased Cardiovascular Risk and an Activated Inflammation: Results from the PIOace Study. Journal of Diabetes Science and Technology 5:4, pages 989-998.
Crossref
Crossref
V. Salini, A. Saggini, G. Maccauro, A. Caraffa, Y.B. Shaik-Dasthagirisaheb & P. Conti. (2011) Inflammatory Markers: Serum Amyloid A, Fibrinogen and C-Reactive Protein — A Revisited Study. European Journal of Inflammation 9:2, pages 95-102.
Crossref
Crossref